# Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device

> **NCT04239105** · — · UNKNOWN · sponsor: **Xijing Hospital** · enrollment: 120 (estimated)

## Conditions studied

- Breast Neoplasms
- Circulating Tumor Cells

## Interventions

- **DEVICE:** Microfluidic and Raman spectrum

## Key facts

- **NCT ID:** NCT04239105
- **Lead sponsor:** Xijing Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01
- **Primary completion:** 2021-07
- **Final completion:** 2022-12
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2020-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04239105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04239105, "Detection of Circulating Tumor Cells in Breast Cancer Patients Using a Novel Microfluidic and Raman Spectrum Device". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04239105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*